Loading...

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Fusions of the RET and ROS1 protein tyrosine kinase oncogenes with several partner genes were recently identified as new targetable genetic aberrations in cases of non-small cell lung cancer (NSCLC) lacking activating EGFR, KRAS, ALK, BRAF, or HER2 oncogene aberrations. RET and ROS1 fusion-positive...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Lung Cancer Res
Main Authors: Kohno, Takashi, Nakaoku, Takashi, Tsuta, Koji, Tsuchihara, Katsuya, Matsumoto, Shingo, Yoh, Kiyotaka, Goto, Koichi
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384213/
https://ncbi.nlm.nih.gov/pubmed/25870798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.11.11
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!